Early T-cell responses in tuberculosis immunity
- PMID: 18837789
- PMCID: PMC3827678
- DOI: 10.1111/j.1600-065X.2008.00693.x
Early T-cell responses in tuberculosis immunity
Abstract
Tuberculosis (TB) has plagued mankind for millennia yet is classified as an emerging infectious disease, because its prevalence in the human population continues to increase. Immunity to TB depends critically on the generation of effective CD4(+) T-cell responses. Sterile immunity has not been achieved through vaccination, although early T-cell responses are effective in controlling steady-state infection in the lungs. Although such early T-cell responses are clearly protective, the initiation of the Mycobacterium tuberculosis (Mtb) T-cell response occurs much later than is the case following other aerogenic infections. This fact suggests that there is a critical period, before the activation of the T-cell response, in which Mtb is able to establish infection. An understanding of the factors that regulate early T-cell activation should, therefore, lead to better control of the disease. This review discusses recent work that has investigated the early development of T-cell immunity following Mtb infection in the mouse.
Figures
Similar articles
-
A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis.J Transl Med. 2018 Oct 11;16(1):279. doi: 10.1186/s12967-018-1653-x. J Transl Med. 2018. PMID: 30305097 Free PMC article.
-
A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette-Guérin (BCG) against Mycobacterium tuberculosis.BMC Infect Dis. 2020 Sep 17;20(1):677. doi: 10.1186/s12879-020-05372-1. BMC Infect Dis. 2020. PMID: 32942991 Free PMC article.
-
Lung Epithelial Signaling Mediates Early Vaccine-Induced CD4+ T Cell Activation and Mycobacterium tuberculosis Control.mBio. 2021 Aug 31;12(4):e0146821. doi: 10.1128/mBio.01468-21. Epub 2021 Jul 13. mBio. 2021. PMID: 34253059 Free PMC article.
-
Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.Clin Exp Immunol. 2012 Sep;169(3):213-9. doi: 10.1111/j.1365-2249.2012.04614.x. Clin Exp Immunol. 2012. PMID: 22861360 Free PMC article. Review.
-
Antigen-specific CD8(+) T cells and protective immunity to tuberculosis.Adv Exp Med Biol. 2013;783:141-63. doi: 10.1007/978-1-4614-6111-1_8. Adv Exp Med Biol. 2013. PMID: 23468108 Free PMC article. Review.
Cited by
-
Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis.Microbiol Spectr. 2023 Aug 17;11(4):e0085823. doi: 10.1128/spectrum.00858-23. Epub 2023 Jun 5. Microbiol Spectr. 2023. PMID: 37272833 Free PMC article.
-
Acute inflammation alters lung lymphocytes and potentiates innate-like behavior in young mouse lung CD8 T cells, resembling lung CD8 T cells from old mice.J Leukoc Biol. 2023 Sep 1;114(3):237-249. doi: 10.1093/jleuko/qiad060. J Leukoc Biol. 2023. PMID: 37196159 Free PMC article.
-
Longitudinal Pathogenesis Study of Young Red Deer (Cervus elaphus) after Experimental Challenge with Mycobacterium avium subsp. paratuberculosis (MAP).Vet Med Int. 2012;2012:931948. doi: 10.1155/2012/931948. Epub 2012 Jun 6. Vet Med Int. 2012. PMID: 22720193 Free PMC article.
-
Harnessing local and systemic immunity for vaccines against tuberculosis.Mucosal Immunol. 2014 Jan;7(1):20-6. doi: 10.1038/mi.2013.99. Epub 2013 Nov 20. Mucosal Immunol. 2014. PMID: 24253104 Review.
-
Bacterial dissemination in Mycobacterium tuberculosis by CD+ T-cells & proinflammatory cytokines.Indian J Med Res. 2023 Jan;158(1):40-46. doi: 10.4103/ijmr.ijmr_2143_21. Indian J Med Res. 2023. PMID: 37602585 Free PMC article.
References
-
- World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. Geneva, Switzerland: World Health Organization; 2007.
-
- Raviglione MC, Smith IM. XDR tuberculosis – implications for global public health. N Engl J Med. 2007;356:656–659. - PubMed
-
- Andersen P. Tuberculosis vaccines – an update. Nat Rev Microbiol. 2007;5:484–487. - PubMed
-
- Young D, Dye C. The development and impact of tuberculosis vaccines. Cell. 2006;124:683–687. - PubMed
-
- Kaufmann SH. Envisioning future strategies for vaccination against tuberculosis. Nat Rev Immunol. 2006;6:699–704. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials